ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

NCI CTEP Approved Trials For the Month of November

November 29, 2013

Murphy Puts RPMI On Record

July 22, 1977

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises

July 21, 1989